Showing results (91-100 of 123) with videos related to

Sort By:
Pageof 13
Arthritis Research & Therapy|May 20, 2015
The association between antibody levels before and after 7-valent pneumococcal conjugate vaccine immunization and subsequent pneumococcal infection in chronic arthritis patientsJohanna Nagel, Pierre Geborek, Tore Saxne, et al.
Rheumatology (Oxford, England)|November 12, 2020
Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquineHeather Miller, Johan K Wallman, Ingemar F Petersson, et al.
Rheumatology (Oxford, England)|July 10, 2010
Patient-reported 28 swollen and tender joint counts accurately represent RA disease activity and can be used to assess therapy responses at the group levelJenny Riazzoli, Jan-Åke Nilsson, Annika Teleman, et al.
Arthritis Care & Research|March 26, 2016
Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish TrialJonas K Eriksson, Johan K Wallman, Heather Miller, et al.
Annals of the Rheumatic Diseases|April 17, 2014
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trialJonas K Eriksson, Johan A Karlsson, Johan Bratt, et al.
Annals of the Rheumatic Diseases|December 1, 2012
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trialJohan A Karlsson, Martin Neovius, Jan-Åke Nilsson, et al.
Physical Therapy|January 30, 2010
How to develop patient-centered research: some perspectives based on surveys among people with rheumatic diseases in ScandinaviaIngvild Kjeken, Connie Ziegler, Jack Skrolsvik, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 20, 2016
A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate FailureKaren Hambardzumyan, Saedis Saevarsdottir, Kristina Forslind, et al.
Annals of the Rheumatic Diseases|January 25, 2013
International comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and SwedenKelvin P Jordan, Anna Jöud, Charlotte Bergknut, et al.
Preventive Medicine Reports|February 7, 2022
Utilization of healthcare and prescription medicines after non-pharmacological interventions for depression - A 3-year register follow-up of an RCT in primary careElisabeth Bondesson, Anna Jöud, Kjerstin Stigmar, et al.
Pageof 13